Klarskov K - Search Results

1

Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.

Miyamae T, Malehorn DE, Lemster B, Mori M, Imagawa T, Yokota S, Bigbee WL, Welsh M, Klarskov K, Nishomoto N, Vallejo AN, Hirsch R. Miyamae T, et al. Among authors: klarskov k. Arthritis Res Ther. 2005;7(4):R746-55. doi: 10.1186/ar1723. Epub 2005 Apr 4. Arthritis Res Ther. 2005. PMID: 15987476 Free PMC article.

2

Molecular basis for the loss of CD28 expression in senescent T cells.

Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ. Vallejo AN, et al. Among authors: klarskov k. J Biol Chem. 2002 Dec 6;277(49):46940-9. doi: 10.1074/jbc.M207352200. Epub 2002 Sep 24. J Biol Chem. 2002. PMID: 12324461 Free article.

3

India ink staining after sodium dodecyl sulfate polyacrylamide gel electrophoresis and in conjunction with Western blots for peptide mapping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Klarskov K, Naylor S. Klarskov K, et al. Rapid Commun Mass Spectrom. 2002;16(1):35-42. doi: 10.1002/rcm.522. Rapid Commun Mass Spectrom. 2002. PMID: 11754245

4

Structural characterization of a case-implicated contaminant, "Peak X," in commercial preparations of 5-hydroxytryptophan.

Klarskov K, Johnson KL, Benson LM, Cragun JD, Gleich GJ, Wrona M, Jiang XR, Dryhurst G, Naylor S. Klarskov K, et al. J Rheumatol. 2003 Jan;30(1):89-95. J Rheumatol. 2003. PMID: 12508395

5

Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan.

Klarskov K, Johnson KL, Benson LM, Gleich GJ, Naylor S. Klarskov K, et al. Adv Exp Med Biol. 1999;467:461-8. doi: 10.1007/978-1-4615-4709-9_58. Adv Exp Med Biol. 1999. PMID: 10721089

6

Structural characterization of contaminants in commercial preparations of melatonin by on-line HPLC-electrospray ionization-tandem mass spectrometry.

Naylor S, Johnson KL, Williamson BL, Klarskov K, Gleich GJ. Naylor S, et al. Among authors: klarskov k. Adv Exp Med Biol. 1999;467:769-77. doi: 10.1007/978-1-4615-4709-9_99. Adv Exp Med Biol. 1999. PMID: 10721130

7

Investigating protein thiol chemistry associated with dehydroascorbate, homocysteine and glutathione using mass spectrometry.

Ahuie GK, Gagnon H, Pace PE, Peskin AV, Wagner RJ, Naylor S, Klarskov K. Ahuie GK, et al. Among authors: klarskov k. Rapid Commun Mass Spectrom. 2020 Jun 15;34(11):e8774. doi: 10.1002/rcm.8774. Rapid Commun Mass Spectrom. 2020. PMID: 32119756

8

Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains.

Fugère M, Limperis PC, Beaulieu-Audy V, Gagnon F, Lavigne P, Klarskov K, Leduc R, Day R. Fugère M, et al. Among authors: klarskov k. J Biol Chem. 2002 Mar 8;277(10):7648-56. doi: 10.1074/jbc.M107467200. Epub 2001 Nov 26. J Biol Chem. 2002. PMID: 11723118 Free article.

9

Dehydroascorbic acid S-Thiolation of peptides and proteins: Role of homocysteine and glutathione.

Ahuié Kouakou G, Gagnon H, Lacasse V, Wagner JR, Naylor S, Klarskov K. Ahuié Kouakou G, et al. Among authors: klarskov k. Free Radic Biol Med. 2019 Sep;141:233-243. doi: 10.1016/j.freeradbiomed.2019.06.022. Epub 2019 Jun 19. Free Radic Biol Med. 2019. PMID: 31228548

10

Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome.

Klarskov K, Gagnon H, Boudreault PL, Normandin C, Plancq B, Marsault E, Gleich GJ, Naylor S. Klarskov K, et al. Toxicol Lett. 2018 Jan 5;282:71-80. doi: 10.1016/j.toxlet.2017.10.012. Epub 2017 Oct 14. Toxicol Lett. 2018. PMID: 29037509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters